These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☑
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended: December 31, 2020
|
|
|
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
|
For the
transition period from
to
|
|
Montana
|
|
81-0305822
|
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
|
|
P.O. Box 643, Thompson Falls, Montana
|
|
59873
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
Securities
registered under Section 12(b) of the Exchange Act:
|
||
|
Title
of each class
|
Trading
Symbol(s)
|
Name of
each exchange on which registered
|
|
|
|
|
|
None
|
N/A
|
N/A
|
|
Title
of each class
|
Trading
Symbol(s)
|
Name of
each exchange on which registered
|
|
|
|
|
|
Common stock, $0.01 par value
|
UAMY
|
NYSE American
|
|
Large
accelerated filer
|
☐
|
|
Accelerated
filer
|
☐
|
|
Non-accelerated
filer
Emerging
Growth Company
|
☐
☐
|
|
Smaller
reporting company
|
☑
|
|
PART I
|
||
|
|
|
|
|
ITEM 1.
|
DESCRIPTION OF BUSINESS
|
1
|
|
|
|
|
|
ITEM 1A.
|
RISK FACTORS
|
5
|
|
|
|
|
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS
|
6
|
|
|
|
|
|
ITEM 2.
|
DESCRIPTION OF PROPERTIES
|
6
|
|
|
|
|
|
ITEM 3.
|
LEGAL PROCEEDINGS
|
12
|
|
|
|
|
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
12
|
|
|
|
|
|
PART II
|
||
|
|
|
|
|
ITEM 5.
|
MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS
|
12
|
|
|
|
|
|
ITEM 6.
|
SELECTED FINANCIAL DATA
|
13
|
|
|
|
|
|
ITEM 7.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF
OPERATIONS
|
13
|
|
|
|
|
|
ITEM 7A.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
|
20
|
|
|
|
|
|
ITEM 7B.
|
CRITICAL ACCOUNTING ESTIMATES
|
20
|
|
|
|
|
|
ITEM 8.
|
FINANCIAL STATEMENTS
|
20
|
|
|
|
|
|
ITEM 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
|
20
|
|
|
|
|
|
ITEM 9A.
|
CONTROLS AND PROCEDURES
|
21
|
|
|
|
|
|
ITEM 9B.
|
OTHER INFORMATION
|
|
|
|
|
|
|
PART III
|
||
|
|
|
|
|
ITEM 10.
|
DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS AND
COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT
|
22
|
|
|
|
|
|
ITEM 11.
|
EXECUTIVE COMPENSATION
|
34
|
|
|
|
|
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
|
25
|
|
|
|
|
|
ITEM 13.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
|
26
|
|
|
|
|
|
ITEM 14.
|
PRINCIPAL ACCOUNTANT FEES AND SERVICE
|
26
|
|
|
|
|
|
PART IV
|
||
|
|
|
|
|
ITEM 15.
|
EXHIBITS AND REPORTS ON FORM 8-K
|
27
|
|
|
|
|
|
SIGNATURES
|
32
|
|
|
|
|
|
|
CERTIFICATIONS
|
|
|
|
|
|
|
|
FINANCIAL
STATEMENTS
|
F-1-F-24
|
|
|
|
Explanatory Note
: As used in this
report, the terms "we," "us" and "our" are used to refer to United
States Antimony Corporation and, as the context requires, its
management.
|
|
|
Schedule of Antimony Sales
|
|||
|
|
Lbs Metal
|
|
Average
|
|
Year
|
Contained
|
$
|
Price/Lb
|
|
2020
|
815,310
|
$
2,942,628
|
$
3.61
|
|
2019
|
1,566,585
|
$
5,450,649
|
$
3.48
|
|
2018
|
1,486,120
|
$
6,113,014
|
$
4.11
|
|
2017
|
1,891,439
|
$
7,588,470
|
$
4.01
|
|
2016
|
2,936,880
|
$
8,744,170
|
$
2.98
|
|
|
For the Year Ended
|
|
|
Sales to Three
|
December 31,
|
December 31,
|
|
Largest Customers
|
2020
|
2019
|
|
Mexichem
Specialty Compounds Inc.
|
$
633,846
|
$
1,823,194
|
|
GE
Chaplin, Inc.
|
589,384
|
-
|
|
Nyacol
Nanotechnologies
|
417,501
|
1,099,504
|
|
Kohler
|
345,899
|
1,132,674
|
|
|
$
1,986,630
|
$
4,055,372
|
|
% of Total Revenues
|
38
%
|
49
%
|
|
USAC SALES
|
|
|
|
Metal
|
|
|
Contained
|
|
Year
|
Price
|
|
2020
|
$
3.61
|
|
2019
|
$
3.48
|
|
2018
|
$
4.11
|
|
2017
|
$
4.01
|
|
2016
|
$
2.98
|
|
Precious Metal Sales
Silver/Gold
|
For the Year Ended December 31,
|
|
|
|
2020
|
2019
|
|
Ounces
Gold Shipped (Au)
|
30.79
|
48.13
|
|
Ounces
Silver Shipped (Ag)
|
11,434
|
11,714
|
|
Revenues
|
$
174,079
|
$
194,239
|
|
Results of Operations by Division
|
|
|
|
For the years ended December 31, 2020 and 2019
|
||
|
|
|
|
|
|
|
|
|
Antimony Division
|
2020
|
2019
|
|
|
|
|
|
Revenues
- Antimony (net of discount)
|
$
2,942,628
|
$
5,450,649
|
|
|
|
|
|
Domestic
cost of sales:
|
|
|
|
Production
costs
|
1,388,065
|
2,352,959
|
|
Depreciation
|
25,809
|
43,738
|
|
Freight
and delivery
|
169,662
|
243,341
|
|
Indirect
production costs
|
139,035
|
164,876
|
|
Direct
sales expense
|
-
|
65,652
|
|
Total
domestic antimony cost of sales
|
1,722,571
|
2,870,566
|
|
|
|
|
|
Mexico
cost of sales:
|
|
|
|
Production
costs
|
471,598
|
3,268,277
|
|
Depreciation
and amortization
|
590,579
|
596,719
|
|
Land
lease expense
|
-
|
166,800
|
|
Indirect
production costs
|
363,206
|
71,329
|
|
Total
Mexico antimony cost of sales
|
1,425,383
|
4,103,125
|
|
|
|
|
|
Total
revenues - antimony
|
2,942,628
|
5,450,649
|
|
Total
cost of sales - antimony
|
3,147,954
|
6,973,691
|
|
Total
gross profit (loss) - antimony
|
(205,326
)
|
(1,523,042
)
|
|
|
|
|
|
Precious Metals Division:
|
|
|
|
|
|
|
|
Revenues
|
174,079
|
194,239
|
|
Cost
of sales:
|
|
|
|
Depreciation
|
86,835
|
69,067
|
|
Total
cost of sales
|
86,835
|
69,067
|
|
Gross
profit - precious metals
|
87,244
|
125,172
|
|
|
|
|
|
Zeolite Division:
|
|
|
|
|
|
|
|
Revenues
|
2,118,823
|
2,623,117
|
|
Cost
of sales:
|
|
|
|
Production
costs
|
1,000,772
|
1,160,502
|
|
Depreciation
|
182,620
|
186,466
|
|
Freight
and delivery
|
223,545
|
269,251
|
|
Indirect
production costs
|
163,231
|
158,891
|
|
Royalties
|
224,875
|
266,388
|
|
Total
cost of sales
|
1,795,043
|
2,041,498
|
|
Gross
profit - zeolite
|
323,781
|
581,619
|
|
|
|
|
|
Company-wide
|
|
|
|
Total
revenues - combined
|
5,235,530
|
8,268,005
|
|
Total
cost of sales - combined
|
5,029,832
|
9,084,256
|
|
Total
gross profit (loss) combined
|
$
205,698
|
$
(816,251
)
|
|
Earnings before income taxes
|
|
|
|
depreciation and amortization
|
|
|
|
For the years ended December 31, 2020 and 2019
|
||
|
|
|
|
|
Antimony - Combined USA
|
|
|
|
and Mexico
|
2020
|
2019
|
|
Lbs
of Antimony Metal USA
|
514,837
|
794,770
|
|
Lbs
of Antimony Metal Mexico
|
300,473
|
771,815
|
|
Total Lbs of Antimony Metal Sold
|
815,310
|
1,566,585
|
|
Average
Sales Price/Lb Metal
|
$
3.61
|
$
3.48
|
|
Net loss/Lb Metal
|
$
(4.46
)
|
$
(2.74
)
|
|
|
|
|
|
Gross
antimony revenue
|
$
2,942,628
|
$
5,450,649
|
|
|
|
|
|
Cost
of sales - domestic
|
(1,722,571
)
|
(2,870,566
)
|
|
Cost
of sales - Mexico
|
(1,425,383
)
|
(4,103,125
)
|
|
Operating
expenses
|
(3,134,889
)
|
(1,451,267
)
|
|
Non-operating
expenses
|
21,808
|
87,798
|
|
Loss
on mineral properties
|
(318,502
)
|
(1,409,022
)
|
|
|
(6,579,537
)
|
(9,746,182
)
|
|
|
|
|
|
Net loss - antimony
|
(3,636,909
)
|
(4,295,533
)
|
|
Depreciation,&
amortization
|
616,388
|
640,457
|
|
EBITDA - antimony
|
$
(3,020,521
)
|
$
(3,655,076
)
|
|
|
|
|
|
Precious Metals
|
|
|
|
Ounces sold
|
|
|
|
Gold
|
31
|
48
|
|
Silver
|
11,434
|
11,714
|
|
|
|
|
|
Gross
precious metals revenue
|
$
174,079
|
$
194,239
|
|
Production
costs
|
(86,835
)
|
(69,067
)
|
|
Net income - precious metals
|
87,244
|
125,172
|
|
Depreciation
|
86,835
|
69,067
|
|
EBITDA - precious metals
|
$
174,079
|
$
194,239
|
|
|
|
|
|
Zeolite
|
|
|
|
Tons sold
|
10,661
|
13,680
|
|
Average
Sales Price/Ton
|
$
198.75
|
$
191.75
|
|
Net income (Loss)/Ton
|
$
24.66
|
$
36.36
|
|
|
|
|
|
Gross
zeolite revenue
|
$
2,118,823
|
$
2,623,117
|
|
Cost
of sales
|
(1,795,043
)
|
(2,041,498
)
|
|
Operating
expenses
|
(57,049
)
|
(68,567
)
|
|
Non-operating
expenses
|
(3,870
)
|
(15,582
)
|
|
Net income - zeolite
|
262,861
|
497,470
|
|
Depreciation
|
182,620
|
186,466
|
|
EBITDA - zeolite
|
$
445,481
|
$
683,936
|
|
|
|
|
|
Company-wide
|
|
|
|
Gross
revenue
|
$
5,235,530
|
$
8,268,005
|
|
Production
costs
|
(5,029,832
)
|
(9,084,256
)
|
|
Operating
expenses
|
(3,191,938
)
|
(1,519,834
)
|
|
Non-operating
expenses
|
17,938
|
72,216
|
|
Loss
on mineral properties
|
(318,502
)
|
(1,409,022
)
|
|
Net income (loss)
|
(3,286,804
)
|
(3,672,891
)
|
|
Depreciation,&
amortization
|
885,843
|
895,990
|
|
EBITDA
|
$
(2,400,961
)
|
$
(2,776,901
)
|
|
recovery
values
|
|
Metal
|
Assay
|
Recovery
|
Value
|
Value/Mt
|
|
|
|
Gold
|
0.035
opmt
|
87.40
%
|
$1,732/oz
|
$
52.98
|
|
|
|
Silver
|
3.27
opmt
|
64.30
%
|
$
25.90/oz
|
$
54.46
|
|
|
|
Antimony
|
0.652
%
|
41.80
%
|
$
5.23/lb
|
$
31.41
|
|
|
|
Total
|
|
|
|
$
138.85
|
|
Financial Condition and Liquidity
|
2020
|
2019
|
|
|
|
|
|
Current
assets
|
$
1,808,161
|
$
1,279,755
|
|
Current
liabilities
|
(4,477,543
)
|
(3,975,681
)
|
|
Net
Working Capital
|
$
(2,669,382
)
|
$
(2,695,926
)
|
|
|
|
|
|
|
|
|
|
|
2020
|
2019
|
|
Cash
provided (used) by operations
|
$
(1,305,664
)
|
$
(11,355
)
|
|
Cash
provided (used) by investing:
|
|
|
|
Cash
used for capital outlay
|
(243,091
)
|
(792,925
)
|
|
Proceeds
from sale of land
|
-
|
400,000
|
|
Cash
provided (used) by financing:
|
|
|
|
Proceeds
from notes payable to bank, net of payments
|
(97,066
)
|
13,149
|
|
Principal
paid on long-term debt
|
(46,670
)
|
(127,683
)
|
|
Advances
from related party
|
-
|
237,400
|
|
Payments
on advances from related parties
|
(83,419
)
|
(35,066
)
|
|
Proceeds
from CARES Act note payable
|
443,400
|
|
|
Stock
issued for cash
|
1,813,068
|
404,199
|
|
Checks
issued and payable
|
69,052
|
(28,849
)
|
|
Net
change in cash and restricted cash
|
$
549,610
|
$
58,870
|
|
Name
|
Age
|
Affiliation
|
Expiration of Term
|
|
John C. Gustavsen
|
72
|
Interim CEO
|
Annual meeting
|
|
|
|
|
|
|
Russell C. Lawrence
|
52
|
Interim President & Director
|
Annual meeting
|
|
|
|
|
|
|
Alicia Hill
|
38
|
Secretary, Controller,
|
Annual meeting
|
|
|
|
and Treasurer
|
|
|
|
|
|
|
|
Hart W. Baitis
|
70
|
Director
|
Annual meeting
|
|
|
|
|
|
|
Dr. Blaise Aguirre
|
55
|
Director
|
Annual meeting
|
|
|
|
|
|
|
Joseph Bardswich
|
73
|
Director
|
Annual meeting
|
|
|
|
|
Total
Fees,
|
|
|
|
|
Awards,
and
|
|
Name and
Principal
|
Fees
Earned
|
Fees
Earned
|
Other
|
|
Position
|
paid in
Cash
|
paid in
Stock
|
Compensation
|
|
Russell
Lawrence,
|
-
|
$
20,000
|
$
20,000
|
|
Interim
President
|
|
|
|
|
Hartmut
Baitis,
|
-
|
$
20,000
|
$
20,000
|
|
Director
|
|
|
|
|
Dr. Blaise
Aquirre,
|
-
|
$
20,000
|
$
20,000
|
|
Director
|
|
|
|
|
Jeffrey
Wright,
|
-
|
$
20,000
|
$
20,000
|
|
Director
|
|
|
|
|
Craig
Thomas,
|
-
|
$
20,000
|
$
20,000
|
|
Director
|
|
|
|
|
John
Lawrence,
|
-
|
$
10,000
|
$
10,000
|
|
Previous
President
|
|
|
|
|
Totals
|
$
-
|
$
110,000
|
$
110,000
|
|
Name and Principal Position
|
Year
|
Salary
|
Bonus
|
Stock Awards (2)
|
Total
|
|
Russell
Lawrence,
Interim
President
|
2020
2019
|
$110,000
$110,000
|
N/A
|
$20,000
$25,000
|
$130,000
$135,000
|
|
John C.
Gustaven,
Interim
CEO
|
2020
2019
|
$100,000
$100,000
|
|
N/A
|
$100,000
$100,000
|
|
Title of Class
|
|
Name and Address of Beneficial Owner
(1)
|
Amount and Nature of Beneficial Ownership
|
Percent of Class
(1)
|
Percent of all Voting Stock
|
|
Series
B Preferred
|
|
Excel
Mineral Company P.O. Box 3800 Santa Barbara, CA 93130
|
750,000
|
100
%
|
N/A
|
|
Series
C Preferred
|
|
Richard
A. Woods 59 Penn Circle West Penn Plasa Apts. Pittsburgh, PA
15206
|
48,305
(4)
|
27.1
%
|
*
|
|
Series
C Preferred
|
|
Dr.
Warren A Evans 69 Ponfret Landing Road Brooklyn, CT
06234
|
32,203
(4)
|
18.1
%
|
*
|
|
Series
C Preferred
|
|
Edward
Robinson 1007 Spruce Street, 1st flor Philadelphia, PA
19107
|
32,203
(4)
|
18
%
|
*
|
|
Series
C Preferred
|
|
All
Series C Preferred Shareholders as a Group
|
177,904
|
100
%
|
*
|
|
|
|
|
|
|
|
|
|
|
John
C. Lawrence
|
4,496,350
|
82.5
%
|
4.2
%
|
|
|
|
Russell
Lawrence
|
495,897
|
9.1
%
|
*
|
|
|
|
Hart
Baitis
|
441,978
|
8.1
%
|
*
|
|
|
|
Blaise
Aquirre
|
17,688
|
0.3
%
|
*
|
|
Common
Stock
|
|
All
Directors and Executive Officers as a Group
|
5,451,913
|
100
%
|
|
|
|
|
|
|
|
|
|
|
|
John
C. Lawrence
|
1,590,672
|
90.8
%
|
1.5
%
|
|
Series
D Preferred
|
|
Leo
Jackson
|
102,000
|
5.8
%
|
*
|
|
|
|
Garry
Babbitt
|
58,333
|
3.3
%
|
*
|
|
Series
D Preferred
|
|
All
Series D Preferred Shareholders as a Group
|
1,751,005
|
100
%
|
1.7
%
|
|
|
|
|
|
|
|
|
Common
Stock and Preferred Stock w/voting rights
|
|
All
Directors and Executive Officers as a Group
|
5,451,913
|
75.7
%
|
5.1
%
|
|
Common
Stock and Preferred Stock w/voting rights
|
|
All
Preferred Shareholders that are officers or directors
|
1,751,005
|
24.3
%
|
1.7
%
|
|
|
|
|
|
|
|
|
Common
and Preferred Voting Stock
|
|
|
7,202,918
|
100.0
%
|
6.8
%
|
|
(1)
|
Beneficial
Ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or
investment power with respect to securities. Shares of common stock
subject to options or warrants currently exercisable or
convertible, or exercisable or convertible within 60 days of March
26, 2021, are deemed outstanding for computing the percentage of
the person holding options or warrants but are not deemed
outstanding for computing the percentage of any other person.
Percentages are based on a total of 108
,994,999
shares of common stock,
750,000 shares of Series B Preferred Stock, 177,904 shares of
Series C Preferred Stock, and 1,751,005 shares of Series D
Preferred Stock outstanding on December 31, 2020. Total voting
stock of 77,878,666 shares is a total of all the common stock
issued, and all of the Series C and Series D Preferred Stock
outstanding at December 31, 2020.
|
|
(2)
|
The
outstanding Series C and Series D preferred shares carry voting
rights equal to the same number of shares of common
stock.
|
|
●
|
Evaluation of the Company’s identification of significant
events or changes in circumstances that have occurred indicating
the underlying Mexican PPE may not be recoverable by performing an
independent assessment.
|
|
●
|
Discussion with management of future business plans for the Mexican
PPE and assessment as to whether the undiscounted future net cash
flow analysis was consistent with the plans.
|
|
●
|
Comparison of key assumptions utilized in the current undiscounted
future net cash analysis to assumptions used in past analyses and
assessed whether the current analysis appropriately reflected the
impact of changes to the Company’s business plans and
operations, current metal prices, actual operating costs, and
industry-specific events.
|
|
●
|
In addition to ensuring key assumptions were consistent with
evidence obtained in other areas of the audit, evaluation of the
significant assumptions and judgements used in the Company’s
analysis including:
|
|
United States Antimony Corporation and Subsidiaries
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
December 31, 2020 and 2019
|
|
|
|
ASSETS
|
|
|
|
|
2020
|
2019
|
|
Current
assets:
|
|
|
|
Cash
and cash equivalents
|
$
665,102
|
$
115,506
|
|
Certificates
of deposit
|
254,212
|
253,552
|
|
Accounts
receivable
|
238,634
|
284,453
|
|
Inventories
|
650,213
|
626,244
|
|
Total
current assets
|
1,808,161
|
1,279,755
|
|
|
|
|
|
Properties,
plants and equipment, net
|
11,225,594
|
12,186,848
|
|
Restricted
cash for reclamation bonds
|
57,275
|
57,261
|
|
IVA
receivable and other assets
|
208,472
|
170,111
|
|
Total
assets
|
$
13,299,502
|
$
13,693,975
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
Current
liabilities:
|
|
|
|
Checks
issued and payable
|
$
86,685
|
$
17,633
|
|
Accounts
payable
|
1,876,874
|
2,328,977
|
|
Payable
to related parties
|
227,432
|
359,309
|
|
Accrued
liabilities
|
635,626
|
638,288
|
|
Notes
payable to bank
|
100,000
|
197,066
|
|
Export
tax assessment payable (Note 13)
|
1,120,730
|
-
|
|
Hillgrove
advances payable (Note 10)
|
378,074
|
378,074
|
|
Long-term
debt, current portion
|
52,122
|
56,334
|
|
Total
current liabilities
|
4,477,543
|
3,975,681
|
|
|
|
|
|
Long-term
debt, net of current portion
|
34,304
|
76,762
|
|
Hillgrove
advances payable (Note 10)
|
756,147
|
756,147
|
|
CARES
Act note payable (Note 17)
|
443,400
|
-
|
|
Stock
payable to directors for services
|
110,000
|
134,375
|
|
Asset
retirement obligations and accrued reclamation costs
|
291,719
|
283,868
|
|
Total
liabilities
|
6,113,113
|
5,226,833
|
|
Commitments
and contingencies (Notes 13 and 15)
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
Preferred
stock $0.01 par value, 10,000,000 shares authorized:
|
|
|
|
Series
A: -0- shares issued and outstanding
|
-
|
-
|
|
Series
B: 750,000 shares issued and outstanding
|
|
|
|
(liquidation
preference $945,000 and $937,500
|
|
|
|
respectively)
|
7,500
|
7,500
|
|
Series
C: 177,904 shares issued and outstanding
|
|
|
|
(liquidation
preference $97,847 both years)
|
1,779
|
1,779
|
|
Series
D: 1,751,005 shares issued and outstanding
|
|
|
|
(liquidation
preference $5,084,770 and $5,043,622
|
|
|
|
respectively)
|
17,509
|
17,509
|
|
Common
stock, $0.01 par value, 150,000,000 shares authorized;
|
|
|
|
75,949,757
and 69,661,436 shares issued and outstanding,
respectively
|
759,496
|
696,614
|
|
Additional
paid-in capital
|
39,050,899
|
37,107,730
|
|
Accumulated
deficit
|
(32,650,794
)
|
(29,363,990
)
|
|
Total
stockholders' equity
|
7,186,389
|
8,467,142
|
|
Total
liabilities and stockholders' equity
|
$
13,299,502
|
$
13,693,975
|
|
United States Antimony Corporation and Subsidiaries
|
||
|
Consolidated Statements of Operations
|
|
|
|
For the years ended December 31, 2020 and 2019
|
||
|
|
|
|
|
|
2020
|
2019
|
|
|
|
|
|
REVENUES
|
$
5,235,530
|
$
8,268,005
|
|
|
|
|
|
COST OF REVENUES
|
5,029,832
|
9,084,256
|
|
|
|
|
|
GROSS PROFIT (LOSS)
|
205,698
|
(816,251
)
|
|
|
|
|
|
OPERATING
EXPENSES:
|
|
|
|
General
and administrative
|
607,365
|
674,494
|
|
Exploration
expense
|
165,183
|
-
|
|
Salaries
and benefits
|
367,491
|
518,758
|
|
Export
tax assessment
|
1,120,920
|
-
|
|
Other
operating expenses
|
684,361
|
88,347
|
|
Professional
fees
|
246,618
|
245,091
|
|
Loss
on mineral properties
|
318,502
|
1,410,736
|
|
TOTAL
OPERATING EXPENSES
|
3,510,440
|
2,937,426
|
|
|
|
|
|
INCOME
(LOSS) FROM OPERATIONS
|
(3,304,742
)
|
(3,753,677
)
|
|
|
|
|
|
OTHER
INCOME (EXPENSE):
|
|
|
|
Interest
expense
|
(17,991
)
|
(78,344
)
|
|
Other
income (expense)
|
35,929
|
159,130
|
|
TOTAL
OTHER INCOME (EXPENSE)
|
17,938
|
80,786
|
|
|
|
|
|
NET INCOME (LOSS)
|
(3,286,804
)
|
(3,672,891
)
|
|
Preferred
dividends
|
(48,649
)
|
(48,649
)
|
|
|
|
|
|
Net
income (loss) available to common stockholders
|
$
(3,335,453
)
|
$
(3,721,540
)
|
|
|
|
|
|
Net
income (loss) per share of common stock:
|
|
|
|
Basic
and diluted
|
$
(0.05
)
|
$
(0.05
)
|
|
|
|
|
|
Weighted
average shares outstanding:
|
|
|
|
Basic
and diluted
|
72,513,814
|
69,004,897
|
|
United States Antimony Corporation and
Subsidiaries
|
|
|
|
|
|
||
|
Consolidated Statements of Changes in Stockholders'
Equity
|
|
|
|
||||
|
For the years ended December 31, 2020 and 2019
|
|
|
|
|
|
||
|
|
|
|
|
|
Additional
|
|
Total
|
|
|
Total Preferred Stock
|
Common Stock
|
Paid
|
Accumulated
|
Stockholders'
|
||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
In Capital
|
Deficit
|
Equity
|
|
Balances,
December 31, 2018
|
2,678,909
|
$
26,788
|
68,227,171
|
682,271
|
$
36,406,874
|
$
(25,691,099
)
|
$
11,424,834
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000
|
2,000
|
134,000
|
|
136,000
|
|
|
Issuance of
common stock to Directors
|
|
|
330,183
|
3,302
|
171,698
|
|
175,000
|
|
Issuance of
common stock for cash
|
|
|
904,082
|
9,041
|
395,158
|
|
404,199
|
|
Net
loss
|
|
|
|
|
|
(3,672,891
)
|
(3,672,891
)
|
|
Balances,
December 31, 2019
|
2,678,909
|
26,788
|
69,661,436
|
696,614
|
37,107,730
|
(29,363,990
)
|
8,467,142
|
|
|
|
|
|
|
|
|
|
|
Issuance
of common stock upon exercise of warrants
|
|
250,000
|
2,500
|
60,000
|
|
62,500
|
|
|
Issuance of
common stock to Directors
|
|
|
295,463
|
2,954
|
127,529
|
|
130,483
|
|
Issuance
of common stock and warrants for cash
|
|
5,742,858
|
57,428
|
1,952,572
|
|
2,010,000
|
|
|
Common stock
issuance costs
|
|
|
|
|
(196,932
)
|
|
(196,932
)
|
|
Net
loss
|
|
|
|
|
|
(3,286,804
)
|
(3,286,804
)
|
|
Balances,
December 31, 2020
|
2,678,909
|
$
26,788
|
75,949,757
|
759,496
|
$
39,050,899
|
$
(32,650,794
)
|
$
7,186,389
|
|
United States Antimony Corporation and Subsidiaries
|
|
|
|
Consolidated Statements of Cash Flows
|
|
|
|
For the years ended December 31, 2020 and 2019
|
|
|
|
|
|
|
|
|
2020
|
2019
|
|
Cash
Flows From Operating Activities:
|
|
|
|
Net
income (loss)
|
$
(3,286,804
)
|
$
(3,672,891
)
|
|
Adjustments
to reconcile net income (loss) to net cash
|
|
|
|
provided
(used) by operating activities:
|
|
|
|
Depreciation
and amortization
|
885,843
|
895,990
|
|
Loss
on mineral properties
|
318,502
|
1,410,736
|
|
Write-down
of inventory to net realizable value
|
-
|
16,396
|
|
Amortization
of debt discount
|
-
|
54,112
|
|
Accretion
of asset retirement obligation
|
7,851
|
6,148
|
|
Common
stock issued for services
|
-
|
136,000
|
|
Common
stock payable for directors' fees
|
106,108
|
134,375
|
|
Other
non cash items
|
(660
)
|
(598
)
|
|
Change
in:
|
|
|
|
Accounts
receivable, net
|
45,819
|
153,938
|
|
Inventories
|
(23,969
)
|
112,621
|
|
IVA
receivable and other assets
|
(38,361
)
|
199,337
|
|
Accounts
payable
|
(452,103
)
|
402,657
|
|
Accrued
liabilities
|
(2,662
)
|
76,416
|
|
Export
tax assessment payable
|
1,120,730
|
-
|
|
Payables
to related parties
|
14,042
|
63,408
|
|
Net
cash provided (used) by operating activities
|
(1,305,664
)
|
(11,355
)
|
|
|
|
|
|
Cash
Flows From Investing Activities:
|
|
|
|
Payment
received on note receivable for sale of land
|
-
|
400,000
|
|
Purchases
of properties, plants and equipment
|
(243,091
)
|
(792,925
)
|
|
Net
cash used by investing activities
|
(243,091
)
|
(392,925
)
|
|
|
|
|
|
Cash
Flows From Financing Activities:
|
|
|
|
Change
in checks issued and payable
|
69,052
|
(28,849
)
|
|
Proceeds
from issuance of common stock and warrants, net of issuance
costs
|
1,813,068
|
404,199
|
|
Advances
from related party
|
-
|
237,400
|
|
Payments
on advances from related party
|
(83,419
)
|
(35,066
)
|
|
Proceeds
from CARES Act note payable
|
443,400
|
-
|
|
Proceeds
(payments) on notes payable to bank, net
|
(97,066
)
|
13,149
|
|
Principal
payments on long-term debt
|
(46,670
)
|
(127,683
)
|
|
Net
cash provided (used) by financing activities
|
2,098,365
|
463,150
|
|
|
|
|
|
NET
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
549,610
|
58,870
|
|
Cash
and cash equivalents and restricted cash at beginning of
period
|
172,767
|
113,897
|
|
Cash
and cash equivalents and restricted cash at end of
period
|
$
722,377
|
$
172,767
|
|
|
|
|
|
SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION
|
|
|
|
Interest
paid in cash
|
$
17,991
|
$
24,233
|
|
Noncash
investing and financing activities:
|
|
|
|
Common
stock payable issued to directors
|
130,483
|
175,000
|
|
Payable
to related party satisfied with exercise of stock
|
|
|
|
purchase
warrant
|
62,500
|
-
|
|
|
December
31,
2020
|
December
31,
2019
|
|
Warrants
|
6,194,899
|
702,041
|
|
Convertible
preferred stock
|
1,751,005
|
1,751,005
|
|
Total possible
dilution
|
7,945,904
|
2,453,046
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2020
|
2019
|
|
Antimony
|
$
2,942,628
|
$
5,450,649
|
|
Zeolite
|
2,118,823
|
2,623,117
|
|
Precious
metals
|
174,079
|
194,239
|
|
|
$
5,235,530
|
$
8,268,005
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2020
|
2019
|
|
United
States
|
$
4,662,841
|
$
7,454,163
|
|
Canada
|
572,689
|
813,842
|
|
Mexico
|
-
|
-
|
|
|
$
5,235,530
|
$
8,268,005
|
|
|
For the Year Ended
|
|
|
Sales to Three
|
December 31,
|
December 31,
|
|
Largest Customers
|
2020
|
2019
|
|
Mexichem
Specialty Compounds Inc.
|
$
633,846
|
$
1,823,194
|
|
GE
Chaplin, Inc.
|
589,384
|
-
|
|
Nyacol
Nanotechnologies
|
417,501
|
1,099,504
|
|
Kohler
|
345,899
|
1,132,674
|
|
|
$
1,986,630
|
$
4,055,372
|
|
% of Total Revenues
|
38
%
|
49
%
|
|
|
December 31,
|
December 31,
|
|
Largest Accounts Receivable
|
2020
|
2019
|
|
Nutreco
Canada Inc.
|
$
21,619
|
$
21,219
|
|
Earth
Innovations Inc.
|
68,055
|
15,184
|
|
Ralco
Mix
|
16,600
|
12,800
|
|
Premier
Tech
|
12,255
|
-
|
|
Lake
Shore
|
-
|
27,854
|
|
Total
|
$
118,529
|
$
77,057
|
|
% of Total Receivables
|
50
%
|
27
%
|
|
Accounts Receivable
|
December 31,
2020
|
December 31,
2019
|
|
Accounts
receivable - non factored
|
$
222,034
|
$
273,573
|
|
Accounts
receivable - factored with recourse
|
16,600
|
10,880
|
|
Accounts
receivable - net
|
$
238,634
|
$
284,453
|
|
|
2020
|
2019
|
|
Antimony
Oxide
|
$
67,377
|
$
204,550
|
|
Antimony
Metal
|
268,100
|
5,654
|
|
Antimony
Ore
|
95,880
|
151,841
|
|
Total
antimony
|
431,357
|
362,045
|
|
Zeolite
|
218,856
|
264,199
|
|
|
$
650,213
|
$
626,244
|
|
|
Antimony
Segment
|
Zeolite
Segment
|
Precious
Metals
|
|
|
|
2020
|
USAC
|
USAMSA
|
BRZ
|
Segment
|
TOTAL
|
|
Plant
and equipment
|
$
815,737
|
$
8,757,775
|
$
3,743,051
|
$
1,266,697
|
$
14,583,260
|
|
Buildings
|
247,210
|
613,449
|
410,780
|
-
|
1,271,439
|
|
Mineral
rights and interests
|
-
|
828,523
|
3,664
|
-
|
832,187
|
|
Land
and other
|
3,274,572
|
2,478,044
|
15,310
|
-
|
5,767,926
|
|
|
4,337,519
|
12,677,791
|
4,172,805
|
1,266,697
|
22,454,812
|
|
Accumulated
depreciation
|
(2,699,781
)
|
(5,042,381
)
|
(3,154,244
)
|
(332,812
)
|
(11,229,218
)
|
|
|
$
1,637,738
|
$
7,635,410
|
$
1,018,561
|
$
933,885
|
$
11,225,594
|
|
|
Antimony Segment
|
Zeolite Segment
|
Precious Metals
|
|
|
|
2019
|
USAC
|
USAMSA
|
BRZ
|
Segment
|
TOTAL
|
|
Plant
and equipment
|
$
783,290
|
$
9,164,600
|
$
3,729,061
|
$
813,714
|
$
14,490,665
|
|
Buildings
|
247,210
|
902,707
|
410,780
|
-
|
1,560,697
|
|
Mineral
rights and interests
|
-
|
816,786
|
3,664
|
-
|
820,450
|
|
Land
and other
|
3,274,572
|
2,529,294
|
15,310
|
-
|
5,819,176
|
|
|
4,305,072
|
13,413,387
|
4,158,815
|
813,714
|
22,690,988
|
|
Accumulated
depreciation
|
(2,673,972
)
|
(4,612,567
)
|
(2,971,625
)
|
(245,976
)
|
(10,504,140
)
|
|
|
$
1,631,100
|
$
8,800,820
|
$
1,187,190
|
$
567,738
|
$
12,186,848
|
|
|
2020
|
2019
|
|
United
States
|
$
2,787,181
|
$
2,961,895
|
|
Mexico
|
8,438,413
|
9,224,953
|
|
Total
|
$
11,225,594
|
$
12,186,848
|
|
Asset Retirement Obligation
|
|
|
|
|
|
Balance
December 31, 2018
|
$
170,220
|
|
Accretion
during 2019
|
6,148
|
|
Balance
December 31, 2019
|
176,368
|
|
Accretion
during 2019
|
7,851
|
|
Balance
December 31, 2019
|
$
184,219
|
|
Long-Term
debt at December 31, 2020 and 2019 is as follows:
|
|
|
|
|
2020
|
2019
|
|
Note
payable to Zeo Inc., non interest bearing,
|
|
|
|
payable
in 11 quarterly installments of $8,300 with a final payment of
$8,700;
|
|
|
|
maturing
December 2022; uncollateralized.
|
$
66,800
|
$
100,000
|
|
Note
payable to Cat Financial Services, bearing interest at
6%;
|
|
|
|
payable
in monthly installments of $778; maturing
|
|
|
|
December
2022; collateralized by equipment.
|
17,480
|
26,250
|
|
Note
payable to De Lage Landen Financial Services,
|
|
|
|
bearing
interest at 3.51%; payable in monthly installments of
$655;
|
|
|
|
maturing
September 2019; collateralized by equipment.
|
|
700
|
|
Note
payable to Phyllis Rice, bearing interest
|
|
|
|
at
1%; payable in monthly installments of $2,000; originally
maturing
|
|
|
|
March
2015; collateralized by equipment.
|
2,146
|
6,146
|
|
|
86,426
|
133,096
|
|
Less
current portion
|
(52,122
)
|
(56,334
)
|
|
Long-term
portion
|
$
34,304
|
$
76,762
|
|
12 Months Ending December 31,
|
Principal Payment
|
|
2021
|
52,122
|
|
2022
|
34,304
|
|
|
$
86,426
|
|
|
2020
|
2019
|
|
Promissory note
payable to First Security Bank of Missoula,
|
|
|
|
bearing interest at
3.150%, payable on demand, collateralized
|
|
|
|
by a lien on
Certificate of Deposit
|
$
99,999
|
$
97,067
|
|
|
|
|
|
Promissory note
payable to First Security Bank of Missoula,
|
|
|
|
bearing interest at
3.150%, payable on demand, collateralized
|
|
|
|
by a lien on
Certificate of Deposit
|
1
|
99,999
|
|
|
|
|
|
Total notes payable
to the bank
|
$
100,000
|
$
197,066
|
|
|
Number of
Warrants
|
Exercise
Prices
|
|
Balance December
31, 2018
|
250,000
|
$
0.25
|
|
Issued
|
452,041
|
$
0.65
|
|
Balance December
31, 2019
|
702,041
|
$
0.25 - $0.65
|
|
Issued
|
5,742,858
|
$
0.46
|
|
Exercised
|
(250,000
)
|
$
0.25
|
|
Balance December
31, 2020
|
6,194,899
|
$
0.46 - $0.65
|
|
|
2020
|
2019
|
|
Domestic
|
$
564,424
|
$
462,292
|
|
Foreign
|
(3,851,228
)
|
(4,135,183
)
|
|
Total
|
$
(3,286,804
)
|
$
(3,672,891
)
|
|
|
2020
|
2019
|
|
Tax
benefit at federal statutory rate
|
$
(690,229
)
|
$
(771,307
)
|
|
State
income tax effect
|
(120,541
)
|
(177,435
)
|
|
Foreign
income tax effect
|
(279,111
)
|
(147,166
)
|
|
Non-deductible
items
|
151
|
801
|
|
Percentage
depletion
|
(27,667
)
|
(52,416
)
|
|
Adjustment
to prior year tax estimates - Domestic
|
580,408
|
(269,906
)
|
|
Adjustment
to prior year tax estimates - Foreign
|
(137,988
)
|
641,438
|
|
Impact
on change in foreign exchange rate
|
75,899
|
103,218
|
|
Change
in valuation allowance - Domestic
|
(393,380
)
|
926,873
|
|
Change
in valuation allowance - Foreign
|
992,458
|
(254,101
)
|
|
Total
|
$
-
|
$
-
|
|
|
2020
|
2019
|
|
Deferred
tax asset:
|
|
|
|
Domestic
net operating loss carry forward
|
$
688,278
|
$
1,111,779
|
|
Foreign
net operating loss carry forward
|
2,616,038
|
1,623,580
|
|
Deferred
tax asset
|
3,304,316
|
2,735,359
|
|
|
|
|
|
Valuation
allowance (domestic)
|
(628,449
)
|
(1,021,829
)
|
|
Valuation
allowance (foreign)
|
(2,616,037
)
|
(1,623,580
)
|
|
Total
deferred tax asset
|
59,830
|
89,950
|
|
|
|
|
|
Deferred
tax liability:
|
|
|
|
Property,
plant, and equipment
|
(57,650
)
|
(88,292
)
|
|
Other
|
(2,180
)
|
(1,658
)
|
|
Total
deferred tax liability
|
(59,830
)
|
(89,950
)
|
|
|
|
|
|
Net
deferred tax asset
|
$
-
|
$
-
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
December 31,
|
|
Total Assets:
|
2020
|
2019
|
|
Antimony
|
|
|
|
United
States
|
$
2,798,283
|
$
2,166,041
|
|
Mexico
|
7,953,190
|
9,193,521
|
|
Subtotal
antimony
|
10,751,473
|
11,359,562
|
|
Precious
metals
|
|
|
|
United
States
|
$
130,882
|
$
143,605
|
|
Mexico
|
803,003
|
424,133
|
|
Subtotal
precious metals
|
933,885
|
567,738
|
|
Zeolite
|
1,614,144
|
1,766,675
|
|
Total
|
$
13,299,502
|
$
13,693,975
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
December 31,
|
|
|
2020
|
2019
|
|
Capital expenditures:
|
|
|
|
Antimony
|
|
|
|
United
States
|
$
32,448
|
$
8,429
|
|
Mexico
|
38,456
|
705,123
|
|
Subtotal
antimony
|
70,904
|
713,552
|
|
Precious
metals
|
|
|
|
United
States
|
10,219
|
21,086
|
|
Mexico
|
147,978
|
-
|
|
Subtotal
precious metals
|
158,197
|
21,086
|
|
Zeolite
|
13,990
|
58,287
|
|
Total
|
$
243,091
|
$
792,925
|
|
Segment Operations for the Year
|
Antimony
|
Antimony
|
Total
|
Precious
|
|
|
|
Ended December 31, 2020
|
USA
|
Mexico
|
Antimony
|
Metals
|
Zeolite
|
Totals
|
|
|
|
|
|
|
|
|
|
Total
revenues
|
$
2,942,628
|
$
-
|
$
2,942,628
|
$
174,079
|
$
2,118,823
|
$
5,235,530
|
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
$
25,809
|
$
590,579
|
$
616,388
|
$
86,835
|
$
182,620
|
$
885,843
|
|
|
|
|
|
|
|
|
|
Income
(loss) from operations
|
$
192,511
|
$
(3,851,228
)
|
$
(3,658,717
)
|
$
87,244
|
$
266,731
|
$
(3,304,742
)
|
|
|
|
|
|
|
|
|
|
Other
income (expense):
|
21,808
|
-
|
21,808
|
-
|
(3,870
)
|
17,938
|
|
|
|
|
|
|
|
|
|
NET INCOME (LOSS)
|
$
214,319
|
$
(3,851,228
)
|
$
(3,636,909
)
|
$
87,244
|
$
262,861
|
$
(3,286,804
)
|
|
Segment Operations for the Year
|
Antimony
|
Antimony
|
Total
|
Precious
|
|
|
|
Ended December 31, 2019
|
USA
|
Mexico
|
Antimony
|
Metals
|
Zeolite
|
Totals
|
|
|
|
|
|
|
|
|
|
Total
revenues
|
$
5,450,649
|
$
-
|
$
5,450,649
|
$
194,239
|
$
2,623,117
|
$
8,268,005
|
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
$
43,738
|
$
596,719
|
$
640,457
|
$
69,067
|
$
186,466
|
$
895,990
|
|
|
|
|
|
|
|
|
|
Income
(loss) from operations
|
$
(144,208
)
|
$
(4,239,123
)
|
$
(4,383,331
)
|
$
125,172
|
$
513,052
|
$
(3,745,107
)
|
|
|
|
|
|
|
|
|
|
Other
income (expense):
|
(16,142
)
|
103,940
|
87,798
|
-
|
(15,582
)
|
72,216
|
|
|
|
|
|
|
|
|
|
NET INCOME (LOSS)
|
$
(160,350
)
|
$
(4,135,183
)
|
$
(4,295,533
)
|
$
125,172
|
$
497,470
|
$
(3,672,891
)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|